Clinical response is associated with elevated plasma interleukin-1 receptor antagonist during selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
Journal: Digestive Diseases And Sciences
Published:
Abstract
Depletion of granulocytes and monocytes (GM) by selective apheresis (GMA) with an Adacolumn exerts an anti-inflammatory effect in patients with ulcerative colitis (UC) or rheumatoid arthritis. However, the mechanism of the anti-inflammatory effect of GMA is not fully understood yet. We investigated the effect of GMA on the plasma concentration of interleukin-1 receptor antagonist (IL-1ra), a potent anti-inflammatory cytokine. Twenty-six patients with active UC received GMA at one session per week for 5 consecutive weeks. Clinical response was defined as Deltaclinical activity index (DeltaCAI=CAI at entry - CAI at post)>or=4, while clinical remission was defined as CAI
Authors
Kyoya Sakimura, Toshihide Omori, Etsuro Iwashita, Takeshi Yoshida, Yoshikazu Tsuzuki, Kenji Fujimori, Fumio Konishi, Yukio Yoshida, Hiroo Anzai, Hiromichi Suzuki, Souichi Sugawara, Yuji Takeda, Katsuya Hiraishi, Abbi Saniabadi, Tatsuo Ide, Soichiro Miura, Shinichi Ota
Relevant Conditions